Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Modeling individual sequential MRD data from phase III trials (MAIA, CASTOR, and POLLUX) using previously developed mathematical models could provide early PFS prediction, guide development and selection of optimal regimens.”
Authors: Walter Gregory, Thomas Prior, Blake Bartlett, Pieter Sonneveld, Meletios Dimopoulos, Philippe Moreau, Saad Usmani, Thierry Facon.
More posts featuring Robert Orlowski.
